Asciminib shows superior tolerability over nilotinib in newly diagnosed CML-CP patients, reducing treatment discontinuation ...

Apotex’s nilotinib capsules are supplied in 3 dosage strengths: 50 mg, 150 mg, and 200 mg. Each carton includes 4 blister packs containing 2 blister cards of 14 capsules each.

A milligram strength for nilotinib tablets ~ 50% lower than that for capsules resulted in bioequivalent nilotinib exposures. Administration with a low-fat meal under modified fasting conditions ...

Xspray Pharma’s XS003 Study Shows Matching Bioavailability to Tasigna at More than a 50% Lower Dose ...

Study Results. From May 2001 through September 2017, we identified 139,233 prescription fills for imatinib made by 7,201 patients, 44,603 fills for dasatinib made by 3,122 patients, and 29,589 ...

Mumbai: Pharma major, Cipla, has received final approval from the United States Food and Drug Administration (USFDA) for the New Drug Application (‘NDA’) submitted for ‘Nilotinib Capsules 50, 150 and ...

Cipla announced that it has received final approval from the United States Food and Drug Administration (USFDA) for the new drug application (NDA) submitted for 'Nilotinib Capsules 50, 150 and 200 mg' ...

Cipla Ltd has received final approval from the United States Food and Drug Administration (USFDA) for its New Drug Application submitted for ‘Nilotinib Capsules 50, 150 and 200 mg’ on 19th February ...

Cipla has received final approval from the US Food and Drug Administration (FDA) for its New Drug Application (NDA) for Nilotinib Capsules in 50 mg, 150 mg, and 200 mg dosages. Nilotinib is indicated ...

Cipla Secures USFDA Nod for Nilotinib, Set for 2025-26 Launch 20 Feb 2025 , 11:46 PM Cipla has got final approval from the USFDA for New Drug Application (NDA) for its Nilotinib Capsules 50 mg ...

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET. 0658 ET – Novartis’s multiple patent expirations and ...